Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positiv
- This topic has 0 replies, 1 voice, and was last updated 4 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/31453370
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.